Evidence map›Paper›PMID 33976232›Full record

ArticleNPJ breast cancer2021

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients.

Sasha E Stanton, Ekram Gad, Erik Ramos, Lauren Corulli, James Annis, Jennifer Childs, Hiroyuki Katayama, Samir Hanash, Jeffrey Marks, Mary L Disis

Open access · goldAbstract read
In one paragraph

Article in NPJ breast cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sasha E StantonCancer Vaccine Institute, University of Washington, Seattle, WA, USA. sasha.stanton@providence.org.
Ekram GadCancer Vaccine Institute, University of Washington, Seattle, WA, USA.
Erik RamosCancer Vaccine Institute, University of Washington, Seattle, WA, USA.
Lauren CorulliCancer Vaccine Institute, University of Washington, Seattle, WA, USA.
James AnnisQuellos High Throughput Facility, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Jennifer ChildsCancer Vaccine Institute, University of Washington, Seattle, WA, USA.
Hiroyuki KatayamaDepartment of Clinical Cancer Prevention, MD Anderson Cancer Center, Houston, TX, USA.
Samir HanashDepartment of Clinical Cancer Prevention, MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey MarksDivision of Surgical Sciences, Duke University, Durham, NC, USA.
Mary L DisisCancer Vaccine Institute, University of Washington, Seattle, WA, USA.
University of Washington · USThe University of Texas MD Anderson Cancer Center · USDuke University · USHigh Throughput Biology (United States) · US

Funding

Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
Immune diagnostics and vaccine targets: breast cancer antigens from mice to womenU01CA141539 · NCI · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2009 to 2013
$3.7M
Adoptive T Cell Therapy for the Treatment of HER2 Overexpressing CancersR01CA129517 · NCI · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2008 to 2011
$2.2M
NCATS NIH HHS KL2 TR000421NCI NIH HHS R01 CA129517NCI NIH HHS U01 CA141539
6 · The paper itself

Abstract

B cell responses to tumor antigens occur early in breast tumors and may identify immunogenic drivers of tumorigenesis. Sixty-two candidate antigens were identified prior to palpable tumor development in TgMMTV-neu and C3(1)Tag transgenic mouse mammary tumor models. Five antigens (VPS35, ARPC2, SERBP1, KRT8, and PDIA6) were selected because their decreased expression decreased survival in human HER2 positive and triple negative cell lines in a siRNA screen. Vaccination with antigen-specific epitopes, conserved between mouse and human, inhibited tumor growth in both transgenic mouse models. Increased IgG autoantibodies to the antigens were elevated in serum from women with ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC). The autoantibodies differentiated women with DCIS from control with AUC 0.93 (95% CI 0.88-0.98, p < 0.0001). The tumor antigens identified early in the development of breast cancer in mouse mammary tumor models were conserved in human disease, and potentially identify early diagnostic markers in human breast tumors.

Identifiers

PMID33976232
PMCPMC8113561
OpenAlexW3163050452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.